Buys
Open market- Shares
- +2,200
- Avg price
- $91.50
- Total value
- +$201,300
Philip P. Boudreau - EVP AND CFO at ABBOTT LABORATORIES
Issuer-level insider activity
- Role
- Evp And Cfo
- Issuer ticker
- ABT on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Philip P. Boudreau in ABBOTT LABORATORIES
Sells
Open market- Shares
- -5,550
- Avg price
- $134.55
- Total value
- -$746,758
Net
Past year- Shares
- -3,350
- Share %
- -43%
- Total value
- -$545,458
Reported holdings for Philip P. Boudreau in ABBOTT LABORATORIES
Form 4 holding
EVP AND CFO
ABBOTT LABORATORIES
- Security class
- Common shares without par value
- Shares / value
- 71,172
- Estimated value
- $7,307,229
- Report date
- 23 Apr 2026
- Price
- $102.67
- Ownership
- Direct
Form 4 holding
EVP AND CFO
ABBOTT LABORATORIES
- Security class
- Common shares without par value
- Shares / value
- 9,276
- Estimated value
- $952,366
- Report date
- 23 Apr 2026
- Price
- $102.67
- Ownership
- Profit Sharing Trust
Form 4 holding
EVP AND CFO
ABBOTT LABORATORIES
- Security class
- Common shares without par value
- Shares / value
- 2,200
- Estimated value
- $201,300
- Report date
- 23 Apr 2026
- Price
- $91.50
- Ownership
- By Spouse
Form 4 holding
EVP AND CFO
ABBOTT LABORATORIES
- Security class
- Option (right to buy)
- Shares / value
- 115,413
- Estimated value
- Report date
- 24 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Philip P. Boudreau in ABBOTT LABORATORIES
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.